Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish Manne

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Medicine|February 16, 2024
Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literatureAdam Khorasanchi, Abraham M Korman, Ashish Manne, et al.
Cancers|May 14, 2022
Changing Landscape of Systemic Therapy in Biliary Tract CancerEdward Woods, Dat Le, Bharath Kumar Jakka, et al.
Oncology Reviews|January 11, 2021
Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelinesSoumya Jogi, Radha Varanai, Sravani S Bantu, et al.
International Journal of Molecular Sciences|September 28, 2023
Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, et al.
International Journal of Molecular Sciences|May 13, 2023
Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical EvidenceAshish Manne, Anup Kasi, Ashwini Kumar Esnakula, et al.
Chinese Clinical Oncology|July 9, 2026
Biliary neuroendocrine tumors: a narrative review of current diagnostics and management strategiesHima B Darapu, Ashish Manne, Anup Kasi, et al.
Chinese Clinical Oncology|April 10, 2023
Management of locally advanced intrahepatic cholangiocarcinoma: a narrative reviewLuke Bressler, Natalie Bath, Ashish Manne, et al.
Cancers|January 21, 2023
Understanding the Clinical Significance of MUC5AC in Biliary Tract CancersKatherine K Benson, Ankur Sheel, Shafia Rahman, et al.
Frontiers in Immunology|May 13, 2022
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint InhibitorsAdithya Chennamadhavuni, Laith Abushahin, Ning Jin, et al.
Oncology Reviews|October 1, 2019
Therapeutic options for ampullary carcinomas. A reviewDileep Kumar Reddy Regalla, Rojymon Jacob, Ashish Manne, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Medicine|February 16, 2024
Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literatureAdam Khorasanchi, Abraham M Korman, Ashish Manne, et al.
Cancers|May 14, 2022
Changing Landscape of Systemic Therapy in Biliary Tract CancerEdward Woods, Dat Le, Bharath Kumar Jakka, et al.
Oncology Reviews|January 11, 2021
Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelinesSoumya Jogi, Radha Varanai, Sravani S Bantu, et al.
International Journal of Molecular Sciences|September 28, 2023
Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, et al.
International Journal of Molecular Sciences|May 13, 2023
Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical EvidenceAshish Manne, Anup Kasi, Ashwini Kumar Esnakula, et al.
Chinese Clinical Oncology|July 9, 2026
Biliary neuroendocrine tumors: a narrative review of current diagnostics and management strategiesHima B Darapu, Ashish Manne, Anup Kasi, et al.
Chinese Clinical Oncology|April 10, 2023
Management of locally advanced intrahepatic cholangiocarcinoma: a narrative reviewLuke Bressler, Natalie Bath, Ashish Manne, et al.
Cancers|January 21, 2023
Understanding the Clinical Significance of MUC5AC in Biliary Tract CancersKatherine K Benson, Ankur Sheel, Shafia Rahman, et al.
Frontiers in Immunology|May 13, 2022
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint InhibitorsAdithya Chennamadhavuni, Laith Abushahin, Ning Jin, et al.
Oncology Reviews|October 1, 2019
Therapeutic options for ampullary carcinomas. A reviewDileep Kumar Reddy Regalla, Rojymon Jacob, Ashish Manne, et al.
Pageof 6